Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1595)
Reports (56)
SAGE documentation (225)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (275)
Americas (766)
Eastern Mediterranean (50)
Europe (707)
South-East Asia (81)
Western Pacific (200)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (69)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (131)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (50)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
4872 results found
2024
∙
NIAC
Updated recommendations for the vaccination of adults against measles
2024
∙
SAGE
Development of WHO immunization policy and strategic guidance
2024
Considerations to inform country COVID-19 vaccination decision-making
2024
∙
ATAGI
ATAGI statement on Nirsevimab for the prevention of severe disease due to respiratory syncytial virus (RSV) in infants
2024
∙
Louise Henaff, Dace Zavadska, Mario Melgar, Johanna Fihman, Christoph Steffen, Joachim Hombach
The role of NITAGs in government decisions on vaccine use: insights from the Fifth Global NITAG Network meeting
2024
∙
NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
2024
Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt, January 2024
2023
∙
Sadat Larijani, M. Doroud, D. Banifazl, M. Karami, A. Bavand, A. Ashrafian, F. Ramezani, A.
A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports
2023
∙
Ikeokwu, A. E. Adeniran, O. F. Marwizi, F. M. Kolade-Ernest, O. J. Solomon, R. O. Ogedengbe, W. Onyemarin-Henry, P. Okpo, N. C. Onyinye, O.
A Meta-Analysis To Ascertain the Effectiveness of COVID-19 Vaccines on Clinical Outcomes in Patients With COVID-19 Infection in North America
2023
∙
Eiden, Amanda L. Barratt, Jane Nyaku, Mawuli K.
A review of factors influencing vaccination policies and programs for older adults globally
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register